Milltrust Ventures will also assist Oncoshot with its expansion in Australia and India, where the latter has already established partnerships amongst apex cancer institutes
Expanded capabilities across pharma services network accelerate innovation and enhance productivity for customers
The investment will accelerate the overall Sarclisa development program
This investment will help BSV avoid carbon dioxide emissions by as much as 6560 tonnes of carbon dioxide equivalent (tCO2e) annually over its project life of 25 years
Srichakra receives European Food Safety approval for its food-grade recycled rPET
A total of 49 projects have been approved so far for 33 critical APIs with a committed investment of Rs 3,685 crore
Feedback and remarks of the industry and stakeholders are invited till the 25th of March 2022
RNA, cell & gene therapies, artificial intelligence, CRISPR and oncology-related deals dominate the landscape
Most recently, Rollins was the Chief Information Officer at UnitedHealthcare
Amit Jaju, Senior Managing Director, India in an interview with Thomas C Thottathil outlined the steps Indian pharma companies should follow to be compliant with global regulatory requirements
Subscribe To Our Newsletter & Stay Updated
